Abbvie (ABBV) PT Raised to $212 at Barclays
Get Alerts ABBV Hot Sheet
Price: $250.82 +0.83%
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Barclays analyst Carter Gould raised the price target on Abbvie (NYSE: ABBV) to $212.00 (from $200.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Wolfe Research Upgrades Abbvie (ABBV) to Outperform
- JPMorgan Downgrades Denso Corp. (6902:JP) (DNZOY) to Underweight
- The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share